Skip to main content

Table 1 Sociodemographic and background information

From: A cross-sectional study on pelvic floor symptoms in women living with Female Genital Mutilation/Cutting

Variable

n (%)

Age (years)

31.5 ± 7.5 (range = 19–54)

BMI

24.59 ± 5.37 (range = 15.2–39.0)

  < 18.5 (underweight)

10 (8.0)

 18.5–24.9 (normal weight)

68 (54.8)

 25.0–29.9 (overweight)

23 (18.6)

  ≥ 30.0 (obesity)

23 (18.6)

Time spent in Switzerland

6.4 ± 7.4 years (range = 13 days–30 years)

  < 1 year

28 (22.5)

 1–2 years

18 (14.5)

 2–3 years

11 (8.9)

 3–4 years

10 (8.1)

 4–5 years

10 (8.1)

  > 5 years

47 (37.9)

Pregnancy at the time of the study

43 (34.7)

 1st trimester

4 (9.3)

 2nd trimester

23 (53.5)

 3rd trimester

16 (37.2)

Type of FGM/C

 

 Type I

9 (7.2)

 Type II

41 (33.1)

 Type III, defibulated

40 (32.3)

 Type III, infibulated

34 (27.4)

Age at FGM/C

 

  < 1 year old

35 (28.2)

 1–5 years old

16 (12.9)

 6–10 years old

40 (32.3)

  > 10 years old

11 (8.9)

 Unknown

22 (17.7)

Previous defibulation (ntot = 74)

 

 Yes, in labour

23 (31.1)

 Yes, during pregnancy

5 (6.8)

 Yes, outside pregnancy

13 (17.6)

 No

32 (43.2)

 Unknown

1 (1.3)

Previous reinfibulation (ntot = 42)

 

 No

35 (83.3)

 Yes

6 (14.3)

 Unknown

1 (2.4)

Past violent events

 

 Physical

5 (4.0)

 Psychological

10 (8.1)

 Sexual

4 (3.2)

 Several (psychological/physical/sexual)

37 (29.9)

 None

64 (51.6)

 No answer

4 (3.2)

Delivery (ntot = 78)

 

 Vaginal

58 (74.4)

 Cesarean section

20 (25.6)

Pelvic organ prolapse4

 

 No

122 (98.4)

 Yes

2 (1.6)

  1. 1Acute complications: hemorrhage, pain, urinary pain, infection
  2. 2Chronic complications: menstrual, sexual, urinary, scarring, obstetric
  3. 3Other ethnic origin: Burkina Faso, Chad, Djibouti, Gambia, Guinea, Guinea-Bissau, Ivory Coast, Mali, Nigeria, Senegal, Sierra Leone, Sudan, Togo
  4. 4Prolapsus stage POP- + : 1 (n = 1), 2 (n = 1)